When was Exservan approved by the FDA?

Written by Teresa Carvalho, MS |

A

When was Exservan approved by the FDA?

Category: Exservan

The U.S. Food and Drug Administration (FDA) approved Exservan in 2019 for the treatment of amyotrophic lateral sclerosis. The medication is administered as a film that is applied on top of the tongue, providing an alternative formulation of riluzole for people with swallowing problems.

Print This Page
Teresa Carvalho, MS avatar

About the Author

Teresa Carvalho, MS Teresa holds her Master of Science in cell and molecular biology from Coimbra University, Portugal. She was a researcher and science communicator for several years at the Institute for Research and Innovation in Health in Oporto, Portugal. From 2013, she has held a fellowship working with Pulmonary Hypertension Europe as a patient advocate, social media/website manager, public relations officer, and translator. Her work has been focused on providing patients access to treatments, raising awareness for pulmonary hypertension, and promoting patient empowerment.


Recommended reading